Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya

BACKGROUND: With the persistent challenges towards controlling the HIV epidemic, there is an ongoing need for research into HIV vaccines and drugs. Sub-Saharan African countries - worst affected by the HIV pandemic - have participated in the conduct of clinical trials for HIV vaccines. In Kenya, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Omosa-Manyonyi, Gloria S., Jaoko, Walter, Anzala, Omu, Ogutu, Hilda, Wakasiaka, Sabina, Malogo, Roselyn, Nyange, Jacqueline, Njuguna, Pamela, Ndinya-Achola, Jeckoniah, Bhatt, Kirana, Farah, Bashir, Oyaro, Micah, Schmidt, Claudia, Priddy, Frances, Fast, Patricia
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024980/
https://www.ncbi.nlm.nih.gov/pubmed/21283743
http://dx.doi.org/10.1371/journal.pone.0014580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024980/
https://www.ncbi.nlm.nih.gov/pubmed/21283743
http://dx.doi.org/10.1371/journal.pone.0014580

Ejemplares similares